Download full-text


Available from: Robert D Kirkcaldy, Oct 15, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Gonorrhea, caused by Neisseria gonorrhoeae is the second most prevalent bacterial sexually transmitted infection. The disease causes serious reproductive complications such as pelvic inflammatory disease, ectopic pregnancy, and infertility, and can facilitate human immunodeficiency virus transmission. Numerous antimicrobial agents have been used for the treatment of gonorrhea since sulfanilamides were introduced in 1936. Unfortunately, N. gonorrhoeae readily develops resistance to antimicrobial agents. Strains with decreased susceptibility to oral third generation cephalosporin (cefixime) are currently emerging. The US Centers for Disease Control and Prevention (CDC) no longer recommends cefixime at any dose as a first-line regimen for treatment of gonococcal infections, but recommends combination therapy with ceftriaxone 250 mg intramuscularly and either azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days as the most reliably effective treatment for uncomplicated gonorrhea.
    01/2013; 8(2):90. DOI:10.14777/kjutii.2013.8.2.90
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pregnant women in the United States are underscreened for chlamydia and gonorrhea, despite recommendations for broad testing. This puts women and infants at risk of complications from untreated infections. Nurses and other clinicians who care for pregnant women have a responsibility to be up-to-date in their knowledge of screening guidelines and to provide appropriate counseling to pregnant women based on their individual risk factors.
    Nursing for Women s Health 04/2013; 17(2):143-6. DOI:10.1111/1751-486X.12023
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gonorrhea is the second most common bacterial sexually transmitted infection in the United States. It continues to be a major cause of morbidity for women and has been linked to infertility and pelvic inflammatory disease. In 2012, the Centers for Disease Control and Prevention revised the current treatment guidelines for gonorrhea in response to the rising rates of antibiotic resistance. This column will discuss the new guidelines, including the rationale for the change as well as nursing implications to support timely and effective treatment of gonorrhea.
    Nursing for Women s Health 06/2013; 17(3):231-5. DOI:10.1111/1751-486X.12037
Show more